PK/PD RELATIONSHIPS IN PATIENTS RECEIVING CONTROLLED-RELEASE (CR) OXYCODONE

被引：0
作者：
ROTH, S
BURCH, F
FLEISCHMANN, R
IWAN, T
FITZMARTIN, R
KAIKO, R
BENZIGER, D
REDER, R
LACOUTURE, P
机构：
[1] ARTHRIT CTR,NORWALK,CT
[2] PURDUE FREDERICK CO,NORWALK,CT
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1995年 / 57卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：165 / 165
页数：1
相关论文
共 50 条
  • [31] Trends and uptake of new formulations of controlled-release oxycodone in Canada
    Gomes, Tara
    Jain, Sonia
    Paterson, J. Michael
    Sketris, Ingrid
    Caetano, Patricia
    Henry, David
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (05) : 520 - 525
  • [32] A double-blind, placebo-controlled, repeated dose, dose-response evaluation of controlled-release (CR) oxycodone in patients with osteoarthritis
    Lacouture, P
    Roth, S
    Burch, F
    Fleischmann, R
    Iwan, T
    Kaiko, R
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI2 - PI2
  • [33] Safety and efficacy of controlled-release oxycodone: A systematic literature review
    Rischitelli, DG
    Karbowicz, SH
    [J]. PHARMACOTHERAPY, 2002, 22 (07): : 898 - 904
  • [34] PHARMACOKINETIC MODEL FOR A NEW ORAL CONTROLLED-RELEASE FORMULATION OF OXYCODONE
    MANDEMA, JW
    KAIKO, RF
    OSHLACK, B
    REDER, RF
    STANSKI, DR
    [J]. ANESTHESIOLOGY, 1994, 81 (3A) : A383 - A383
  • [35] Noninterventional Observational Study Using High-Dose Controlled-Release Oxycodone (CR Oxycodone) for Cancer Pain Management in Outpatient Clinics
    Baek, Sun Kyung
    Shin, Hye Won
    Choi, Young Jin
    Zang, Dae Young
    Cho, Do-Yeun
    Ryoo, Hun Mo
    Baek, Jin Ho
    Kim, Sam Yong
    Song, Hong-Suk
    [J]. PAIN MEDICINE, 2013, 14 (12) : 1866 - 1872
  • [36] Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain
    Hagen, NA
    Babul, N
    [J]. CANCER, 1997, 79 (07) : 1428 - 1437
  • [37] Clinical Equivalence of Controlled-Release Oxycodone 20 mg and Controlled-Release Tramadol 200 mg after Surgery for Breast Cancer
    Kampe, Sandra
    Wolter, Karsten
    Warm, Mathias
    Dagtekin, Oguzhan
    Shaheen, Sasan
    Landwehr, Susanne
    [J]. PHARMACOLOGY, 2009, 84 (05) : 276 - 281
  • [38] Double-blind, randomized, two-period crossover efficacy and pharmacokinetic comparison of immediate-release oxycodone (IR) and controlled-release oxycodone (CR) in cancer patients with pain.
    Stambaugh, JE
    Reder, RF
    Stambaugh, M
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII13 - PII13
  • [39] Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma
    Claudio Cartoni
    Gregorio Antonio Brunetti
    Vincenzo Federico
    Fabio Efficace
    Sara Grammatico
    Andrea Tendas
    Laura Scaramucci
    Luca Cupelli
    Gianna Maria D’Elia
    Andrea Truini
    Pasquale Niscola
    Maria Teresa Petrucci
    [J]. Supportive Care in Cancer, 2012, 20 : 2621 - 2626
  • [40] Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma
    Cartoni, Claudio
    Brunetti, Gregorio Antonio
    Federico, Vincenzo
    Efficace, Fabio
    Grammatico, Sara
    Tendas, Andrea
    Scaramucci, Laura
    Cupelli, Luca
    D'Elia, Gianna Maria
    Truini, Andrea
    Niscola, Pasquale
    Petrucci, Maria Teresa
    [J]. SUPPORTIVE CARE IN CANCER, 2012, 20 (10) : 2621 - 2626
12345